“Patients in the investigational group experienced a significantly greater reduction in sleep disturbances, and in agitation and aggression,” researchers concluded.
Archives: News Releases
Since 1992, every Thursday and when breaking news warrants, NORML | The NORML Foundation have been issuing weekly press releases for marijuana law supporters and the media.
NORML’s News Releases archives goes back to 1996 and serves as a valuable tool to alert citizens about cannabis-related news and legislation as well as a research tool for reviewing a chronology of marijuana law reform.
The study’s authors concluded, “Medical cannabis is associated with therapeutic effects on pain in older adults with an acceptable safety profile.”
“CBD may have key advantages over existing [SAD] treatments,” authors suggested.
Among patients administered extracts for a period of at least one year, 51 percent experienced a significant decline in seizure frequency.
Authors reported that less than one-half of one percent of subjects reported ever having had a cannabis-induced acute psychotic episode during their lifetime.
Researchers reported that the percentage of consumers who grew their own cannabis increased from six percent prior to the passage of legalization to nine percent in 2020.
The new rules will take effect on October 5, 2022.
Investigators reported, “Our results revealed significant improvements in [the] overall … scores of the ASD participants, … particularly [among] those with more severe initial symptoms.”